11/15
08:04 am
bmy
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/15
08:04 am
bmy
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
Medium
Report
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Wolfe Research. They set a "peer perform" rating on the stock.
11/15
05:18 am
bmy
Rating for BMY
Medium
Report
Rating for BMY
11/15
05:18 am
bmy
Rating for BMY
Medium
Report
Rating for BMY
11/14
04:13 pm
bmy
Bristol Myers initiated with neutral view at Wolfe Research
Medium
Report
Bristol Myers initiated with neutral view at Wolfe Research
11/14
04:13 pm
bmy
Bristol Myers initiated with neutral view at Wolfe Research
Medium
Report
Bristol Myers initiated with neutral view at Wolfe Research
11/13
10:07 am
bmy
Bristol-Myers Squibb (NYSE: BMY) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to an "outperform" rating.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) was upgraded by analysts at Daiwa Capital Markets from a "neutral" rating to an "outperform" rating.
11/12
01:56 pm
bmy
Rating for BMY
Low
Report
Rating for BMY
11/12
01:56 pm
bmy
Rating for BMY
Low
Report
Rating for BMY
11/12
11:27 am
bmy
Rating for BMY
Low
Report
Rating for BMY
11/12
11:27 am
bmy
Rating for BMY
Low
Report
Rating for BMY
11/12
08:25 am
bmy
Rating for BMY
Low
Report
Rating for BMY
11/12
08:25 am
bmy
Rating for BMY
Low
Report
Rating for BMY
11/12
08:19 am
bmy
Bristol-Myers Squibb (NYSE: BMY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $73.00 price target on the stock.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) was upgraded by analysts at Leerink Partners from a "market perform" rating to an "outperform" rating. They now have a $73.00 price target on the stock.
11/12
07:53 am
bmy
Rating for BMY
Low
Report
Rating for BMY
11/1
11:34 am
bmy
Rating for BMY
Low
Report
Rating for BMY
11/1
11:34 am
bmy
Rating for BMY
Low
Report
Rating for BMY
10/25
08:30 am
bmy
Rating for BMY
Low
Report
Rating for BMY
10/25
08:30 am
bmy
Rating for BMY
Low
Report
Rating for BMY
10/25
07:42 am
bmy
Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $55.00 price target on the stock, down previously from $75.00.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) was downgraded by analysts at Citigroup Inc. from a "buy" rating to a "neutral" rating. They now have a $55.00 price target on the stock, down previously from $75.00.
10/18
08:33 am
bmy
Bristol-Myers Squibb (NYSE: BMY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $50.00 price target on the stock.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $50.00 price target on the stock.
10/18
07:54 am
bmy
Rating for BMY
Low
Report
Rating for BMY
10/17
12:32 pm
bmy
Rating for BMY
Low
Report
Rating for BMY
10/17
12:32 pm
bmy
Rating for BMY
Low
Report
Rating for BMY
10/17
08:13 am
bmy
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $56.00 price target on the stock.
Low
Report
Bristol-Myers Squibb (NYSE: BMY) is now covered by analysts at Sanford C. Bernstein. They set a "market perform" rating and a $56.00 price target on the stock.